RBCB1500
| Blyscan™ Dye & Dissociation Reagents
|
| BioVendor
|
|
|
|
| 558 €
|
RBCB1005
| Blyscan™ Dye Reagent
|
| BioVendor
|
|
|
|
| 551 €
|
RBCB1007
| Blyscan™ Dissociation Reagent
|
| BioVendor
|
|
|
|
| 502 €
|
RBCB3000
| Blyscan™ sGAG Assay (Large Economy Size)
|
| BioVendor
|
|
|
|
| 1.396 €
|
RBCS1011
| Sircol™ Rat Collagen Reference Standard (0.5 mg/ml)
|
| BioVendor
|
|
|
|
| 326 €
|
RBCSFRAG
| S2000 Fragmentation Reagent
|
| BioVendor
|
|
|
|
| 262 €
|
RBCS2000
| Sircol™ Insoluble Collagen Assay, Bovine Collagen (Standard Kit Size)
|
| BioVendor
|
|
|
|
| 509 €
|
RBCS1500
| Sircol™ Dye & Dye Release Reagents
|
| BioVendor
|
|
|
|
| 622 €
|
RBCS6000
| Sircol™ Insoluble Collagen Assay (Large Economy Kit)
|
| BioVendor
|
|
|
|
| 1.277 €
|
RBCB1000
| Blyscan™ sGAG Assay (Standard Kit Size)
|
| BioVendor
|
|
|
|
| 551 €
|
RBCSWASH
| Sircol™ Acid-Salt Wash
|
| BioVendor
|
|
|
|
| 305 €
|
RBCF2000
| Fastin™ Elastin Assay (Standard Kit Size)
|
| BioVendor
|
|
|
|
| 593 €
|
RBCB1010
| Blyscan™ sGAG Reference Standard (100 µg/ml)
|
| BioVendor
|
|
|
|
| 291 €
|
RBCS5000
| Sircol™ Soluble Collagen Assay (Large Economy Kit)
|
| BioVendor
|
|
|
|
| 1.354 €
|
RBCSICR
| Sircol™ Isolation & Concentration Reagent
|
| BioVendor
|
|
|
|
| 305 €
|
RBCF4000
| Fastin™ Elastin Assay (Large Economy Kit)
|
| BioVendor
|
|
|
|
| 1.544 €
|
RBCS1007
| Sircol™ Dye Release Reagent
|
| BioVendor
|
|
|
|
| 319 €
|
RBCS1111
| Sircol™ Soluble Collagen Assay, Rat Collagen (Standard Kit Size)
|
| BioVendor
|
|
|
|
| 551 €
|
RBCF2010
| Fastin™ Elastin Reference Standard (1 mg/ml)
|
| BioVendor
|
|
|
|
| 340 €
|
RBCS1005
| Sircol™ Dye Reagent
|
| BioVendor
|
|
|
|
| 593 €
|
RBCB1015
| Blyscan™ sGAG Isolation & Concentration Pack
|
| BioVendor
|
|
|
|
| 340 €
|
RBCS4000
| Sircol™ Soluble plus Sircol™ Insoluble Collagen Combination Pack
|
| BioVendor
|
|
|
|
| 889 €
|
RBCS1010
| Sircol™ Bovine Collagen Reference Standard (0.5 mg/ml)
|
| BioVendor
|
|
|
|
| 305 €
|
RBCS1000
| Sircol™ Soluble Collagen Assay, Bovine Collagen (Standard Kit Size)
|
| BioVendor
|
|
|
|
| 530 €
|
RBCF2300
| Fastin™ Dye Reagent
|
| BioVendor
|
|
|
|
| 1.058 €
|
RBCH2000
| Purple-Jelley Hyaluronan Assay (Economy Kit)
|
| BioVendor
|
|
|
|
| 1.417 €
|
RMS01
| Haptoglobin Phenotype MALDI MS
|
| BioVendor
|
|
|
|
| A consultar
|
RBCS2010
| S2000 Denatured Collagen Standard (1 mg/ml)
|
| BioVendor
|
|
|
|
| 291 €
|
RBCH1000
| Purple-Jelley Hyaluronan Assay (Standard Kit)
|
| BioVendor
|
|
|
|
| 558 €
|
Stm130Sur-01
| 1. Gastroesophageal junctional carcinoma, 65 cases.
2. Survival information available, being followed up for 3.5-7 years.
| 1.5mm
| USBiolab
|
|
|
|
| € 840,00
|
LugA150Sur-01
| 1. Lung adenocarcinoma (75 cases), tumor (1 core/dase) and matched normal adjacent tissue (1 core/case).
2. Survival information available. Being followed up for more than 5 years.
3. With IHC data of VEGF and survivin.
| 1.5mm
| USBiolab
|
|
|
|
| € 985,00
|
MorgH090-01
| 1. Multiple organ (29 types) from aborted fetus (5 cases). 1-5 cases/organ, 1 core/case.
2. Esophagus, stomach, duodenum, jejunum, ileum, liver, pancreas, lung, heart, aorta, ovary, testis, adrenal, kidney, bladder, ureter, pituitary, cerebrum, hippocam
| 2.0mm
| USBiolab
|
|
|
|
| € 503,00
|
Eso127-01
| 1. Esophagus squamous cell carcinoma (50 cases), 27 cases have tumor(1 core/case) and matched normal adjacent tissue (1 core/case) and negative/positive lymph node (1 core/case), 23 cases have tumor tissue (1 core/case) and positive lymph node (1 core/cas
| 1.5mm
| USBiolab
|
|
|
|
| € 400,00
|
Liv01-002
| 1. Liver carcinoma (80 cases), 2 cores/case. Normal adjacent tissue (10 cases), 2 cores/case. Other tumor tissue (20 cases), 1 core/case.
2. Pathology grade 1, 2, 3.
| 1.0mm
| USBiolab
|
|
|
|
| € 255,00
|
Kid02-003
| 1. Kidney clear cell carcinoma (32 cases), 1 core/case.
2. Pathology grade 2-3, 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
Lug02-003
| 1. Lung squamous cell carcinoma (32 cases), 1 core/case.
2. Pathology grade 2-3, 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
Liv02-003
| 1. Hepatocellular carcinoma (32 cases), 1 core/case.
2. Pathology grade 2-3, 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
Pan180Sur-01
| 1. Pancreatic adenocarcinoma (90 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). Clinical stage I, II, IV (Version 7.0).
2. Survival information available. Being followed up for 3-7 years.
3. Smoking history, drinking histo
| 1.5mm
| USBiolab
|
|
|
|
| € 1.571,00
|
Liv01-008
| 1. Hepatocellular carcinoma (100 cases, pathology grade I, II, III).
2. Sclerosing hepatocellular carcinoma (5 cases)
3. Liver cirrhosis (20 cases)
4. 3 cores/case.
| 1.0mm
| USBiolab
|
|
|
|
| € 372,00
|
Eso4-007
| 1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case.
2. Pathology grade 1, 1-2, 2, 2-3, 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 241,00
|
Rau120Sur-01
| 1. Kidney pelivis carcinoma and ureter carcinoma, 120cases. Tumor, 1 core/case
2. Survival information available. Being followed up for 0.5-7 years.
| 1.5mm
| USBiolab
|
|
|
|
| € 840,00
|
Rec02-002
| 1. Rectum adenocarcinoma (32 cases), 1 core/case.
2. Pathology grade 2.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
Eso03-003
| 1. Esophagus carcinoma (21 cases), containing squamous cell carcinoma (9 cases), adenocarcinoma (5 cases), small cell carcinoma ( 6 cases) and undifferentiated carcinoma (1 case). Esophagogastric junction carcinoma (8 cases). Gastric carcinoma (2 cases
| 2.0mm
| USBiolab
|
|
|
|
| € 241,00
|
ColM060CS-01
| 30 cases of mucous adenocarcinoma of colon /normal adjacent tissue, 1 core/case.Clinical stage I-IV.
| 2.0mm
| USBiolab
|
|
|
|
| € 286,00
|
Stm150CS-01
| 1. Early stomach adenocarcinoma, 75 cases. Tumor and normal adjacent tissue. 2 cores/case.
2. Clinical Stage I. 29 cases of T1N0M0, 5 cass of T1N1M0, 41 cases of T2N0M0.
| 1.5mm
| USBiolab
|
|
|
|
| € 695,00
|
Liv04-001
| 1. Hepatocellular carcinoma (41 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case).
2. Pathology grade 1, 2, 3.
3. Paired frozen samples accessible.
| 2.0mm
| USBiolab
|
|
|
|
| € 283,00
|
Stm150CS-02
| 1. stomach adenocarcinoma, 75 cases. Tumor and normal adjacent tissue. 2 cores/case.
2. 15 cases of clinical Stage I . 25 cases of stage II, 25 cass of stage III, 10 cases of stage IV.(all cases overlapped with Stm180-01)
| 1.5mm
| USBiolab
|
|
|
|
| € 476,00
|
Bre01-003
| 1. Breast carcinoma (80 cases), 2 cores/case. Normal adjacent tissue (10 cases), 2 cores/case. Other carcinoma (20 cases), 1 core/case.
2. Pathology grade 1, 2, 3.
3. ER, PR information.
| 1.0mm
| USBiolab
|
|
|
|
| € 325,00
|
Rec180Sur-04
| 1. Rectum adenocarcinoma (90 cases) with survival information, tumor ( 1 core/case) and matched normal adjacent tissue. Clinical stage I-IV (Version 7.0).
2. Surgery date 2007.10 - 2008.10, visit date 2012.8. Being followed up for 5-6 years.
| 1.5mm
| USBiolab
|
|
|
|
| € 1.130,00
|
Stm02-004
| 1. Signet ring cell carcinoma (32 cases), 1 core/case.
2. Pathology grade 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|